200 related articles for article (PubMed ID: 20370848)
21. Update on advances in molecular PET in urological oncology.
Kitajima K; Yamamoto S; Fukushima K; Minamimoto R; Kamai T; Jadvar H
Jpn J Radiol; 2016 Jul; 34(7):470-85. PubMed ID: 27222021
[TBL] [Abstract][Full Text] [Related]
22. Chronic myeloid leukemia detected on FDG PET/CT imaging in a patient with renal cell carcinoma.
Varoglu E; Kaya B; Sari O
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):43-5. PubMed ID: 23177344
[TBL] [Abstract][Full Text] [Related]
23. A new method for detecting urinary bladder cancer by using FDG PET/CT.
Chen YK; Yeh CH; Su CT; Tsui CC; Cheng RH; Hung GU; Kao CH
Technol Cancer Res Treat; 2014 Aug; 13(4):369-76. PubMed ID: 24206206
[TBL] [Abstract][Full Text] [Related]
24. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients.
Tagliabue L; Del Sole A
Eur J Intern Med; 2014 Jan; 25(1):6-11. PubMed ID: 23910561
[TBL] [Abstract][Full Text] [Related]
25. Clinical applications of PET and PET/CT in pediatric malignancies.
Kumar R; Shandal V; Shamim SA; Halanaik D; Malhotra A
Expert Rev Anticancer Ther; 2010 May; 10(5):755-68. PubMed ID: 20470007
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
Sahiner I; Akkas BE; Ucmak Vural G
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
[TBL] [Abstract][Full Text] [Related]
27. [Positron emission tomography (PET) and PET-CT in renal, bladder and prostate cancer: update].
Delgado Bolton RC; Mucientes Rasilla J; Pérez Castejón MJ; Carreras Delgado JL
Actas Urol Esp; 2009 Jan; 33(1):11-23. PubMed ID: 19462720
[TBL] [Abstract][Full Text] [Related]
28. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
29. [Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].
Machtens S; Boerner AR; Hofmann M; Knapp WH; Jonas U
Urologe A; 2004 Nov; 43(11):1397-409. PubMed ID: 15502907
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours.
González-Ruiz de León C; García-Rodríguez J; Pérez-Castro N; Vigil-Díaz C; Pérez-Haro ML; Fernández-Gómez JM
Actas Urol Esp (Engl Ed); 2019; 43(1):32-38. PubMed ID: 30100141
[TBL] [Abstract][Full Text] [Related]
31. [Why is PET/CT essential in urooncology?].
Borbély K; Géczi L; Kásler M
Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
[TBL] [Abstract][Full Text] [Related]
32. Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers.
Gauthé M; Richard-Molard M; Cacheux W; Michel P; Jouve JL; Mitry E; Alberini JL; Lièvre A;
Dig Liver Dis; 2015 Jun; 47(6):443-54. PubMed ID: 25766918
[TBL] [Abstract][Full Text] [Related]
33. High-grade urothelial carcinoma of the prostate on FDG PET-CT.
Ho L; Quan V; Henderson R; Seto J
Clin Nucl Med; 2007 Sep; 32(9):746-7. PubMed ID: 17710037
[TBL] [Abstract][Full Text] [Related]
34. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET/CT in lung cancer: an update.
Baum RP; Świętaszczyk C; Prasad V
Front Radiat Ther Oncol; 2010; 42():15-45. PubMed ID: 19955789
[TBL] [Abstract][Full Text] [Related]
36. Recent developments in urologic oncology: positron emission tomography molecular imaging.
Bouchelouche K; Oehr P
Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
[TBL] [Abstract][Full Text] [Related]
37. [Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
Schriefer P; Hartmann M; Oechsle K; Meyer CP; Klutmann S; Fisch M; Bokemeyer C; Oing C
Urologe A; 2019 Apr; 58(4):418-423. PubMed ID: 30374517
[TBL] [Abstract][Full Text] [Related]
38. [PET-FDG in metastases from urological malignancies].
Labarthe P; Méjean A; Lebret T
Prog Urol; 2008 Nov; 18 Suppl 7():S208-12. PubMed ID: 19070793
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
Bouchelouche K; Oehr P
J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
[TBL] [Abstract][Full Text] [Related]
40. PET in prostate and bladder tumors.
Lee ST; Lawrentschuk N; Scott AM
Semin Nucl Med; 2012 Jul; 42(4):231-46. PubMed ID: 22681672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
